Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 87
Filter
1.
Prostate ; 82(13): 1273-1283, 2022 09.
Article in English | MEDLINE | ID: mdl-35747940

ABSTRACT

BACKGROUND: Previously we reported that arsenic and estrogen cause synergistic effects in the neoplastic transformation of human prostate epithelial cells. In addition to receptor-mediated pathways, DNA-reactive estrogen metabolites have also been shown to play a critical role in mutagenicity and carcinogenicity. Both estrogen and arsenic are known prostate carcinogens, however, the effect of coexposure to these two chemicals on genes involved in estrogen metabolism is not known. Therefore, the objective of this study was to evaluate the role of arsenic and estrogen coexposure on the expression of estrogen receptors and estrogen metabolism-associated genes. Earlier, we also reported the synergistic effect of arsenic and estrogen on decreased expression of MBD4 genes that play an important role in DNA repair through its DNA glycosylase activity. To further understand the mechanism, the promoter methylation of this gene was also analyzed. METHODS: Total RNA and protein were isolated from RWPE-1 human prostate epithelial cells that were coexposed to arsenic and estrogen for a chronic duration (6Ā months). The expression of estrogen receptors, estrogen metabolism associated phase I genes (CYP 1A1, 1A2, 3A4, and 1B1) and phase II gene catechol-O-methyltransferase (COMT), as well as antioxidant MnSOD, were analyzed either at the RNA level by quantitativeĀ reverse transcriptase-polymeraseĀ chain reactionĀ or at the protein level by western blot. Promoter methylation of MBD4 was analyzed by pyrosequencing. RESULTS: Expression of MnSOD and phase I genes that convert E2 into genotoxic metabolites 2-OH-E2 and 4-OH-E2 were significantly increased, whereas the expression of phase II gene COMT that detoxifies estrogen metabolites was significantly decreased in arsenic and estrogen coexposed cells. MBD4 promoter was hypermethylated in arsenic and estrogen coexposed cells. Coexposure to arsenic and estrogen has synergistic effects on the expression of these genes as well as in MBD4 promoter hypermethylation. CONCLUSIONS: These novel findings suggest that coexposure to arsenic and estrogen acts synergistically in the activation of not only the estrogen receptors but also the genes associated with genotoxic estrogen metabolism and epigenetic inactivation of DNA glycosylase MBD4. Together, these genetic and epigenetic aberrations provide the molecular basis for the potentiation of carcinogenicity of arsenic and estrogen coexposure in prostate epithelial cells.


Subject(s)
Arsenic , DNA Damage , DNA Glycosylases , Estrogens , Prostate , Arsenic/metabolism , Arsenic/toxicity , Catechol O-Methyltransferase/genetics , Catechol O-Methyltransferase/metabolism , Catechol O-Methyltransferase/pharmacology , DNA Damage/drug effects , DNA Damage/genetics , DNA Glycosylases/genetics , DNA Glycosylases/metabolism , DNA Glycosylases/pharmacology , DNA Methylation , Endodeoxyribonucleases/genetics , Endodeoxyribonucleases/metabolism , Endodeoxyribonucleases/pharmacology , Environmental Exposure , Epithelial Cells/drug effects , Epithelial Cells/metabolism , Estrogens/adverse effects , Estrogens/pharmacology , Humans , Male , Metabolic Networks and Pathways , Prostate/drug effects , Prostate/metabolism , Prostate/pathology , RNA , Receptors, Estrogen/genetics , Receptors, Estrogen/metabolism
2.
J Neurosci ; 35(28): 10188-201, 2015 Jul 15.
Article in English | MEDLINE | ID: mdl-26180195

ABSTRACT

Usher syndrome type III (USH3) is characterized by progressive loss of hearing and vision, and varying degrees of vestibular dysfunction. It is caused by mutations that affect the human clarin-1 protein (hCLRN1), a member of the tetraspanin protein family. The missense mutation CLRN1(N48K), which affects a conserved N-glycosylation site in hCLRN1, is a common causative USH3 mutation among Ashkenazi Jews. The affected individuals hear at birth but lose that function over time. Here, we developed an animal model system using zebrafish transgenesis and gene targeting to provide an explanation for this phenotype. Immunolabeling demonstrated that Clrn1 localized to the hair cell bundles (hair bundles). The clrn1 mutants generated by zinc finger nucleases displayed aberrant hair bundle morphology with diminished function. Two transgenic zebrafish that express either hCLRN1 or hCLRN1(N48K) in hair cells were produced to examine the subcellular localization patterns of wild-type and mutant human proteins. hCLRN1 localized to the hair bundles similarly to zebrafish Clrn1; in contrast, hCLRN1(N48K) largely mislocalized to the cell body with a small amount reaching the hair bundle. We propose that this small amount of hCLRN1(N48K) in the hair bundle provides clarin-1-mediated function during the early stages of life; however, the presence of hCLRN1(N48K) in the hair bundle diminishes over time because of intracellular degradation of the mutant protein, leading to progressive loss of hair bundle integrity and hair cell function. These findings and genetic tools provide an understanding and path forward to identify therapies to mitigate hearing loss linked to the CLRN1 mutation. SIGNIFICANCE STATEMENT: Mutations in the clarin-1 gene affect eye and ear function in humans. Individuals with the CLRN1(N48K) mutation are born able to hear but lose that function over time. Here, we develop an animal model system using zebrafish transgenesis and gene targeting to provide an explanation for this phenotype. This approach illuminates the role of clarin-1 and the molecular mechanism linked to the CLRN1(N48K) mutation in sensory hair cells of the inner ear. Additionally, the investigation provided an in vivo model to guide future drug discovery to rescue the hCLRN1(N48K) in hair cells.


Subject(s)
Gene Expression Regulation, Developmental/genetics , Hair Cells, Auditory/pathology , Membrane Proteins/metabolism , Usher Syndromes/pathology , Zebrafish Proteins/metabolism , Animals , Animals, Genetically Modified , Auditory Pathways/metabolism , Auditory Pathways/pathology , Body Patterning/drug effects , Body Patterning/genetics , Cadherins/genetics , Disease Models, Animal , Endodeoxyribonucleases/pharmacology , Female , Gene Expression Regulation, Developmental/drug effects , Genotype , Hearing Loss/genetics , Humans , Larva , Male , Membrane Proteins/genetics , Mutation/genetics , Postural Balance/genetics , Sequence Analysis, Protein , Synapses/metabolism , Synapses/pathology , Usher Syndromes/complications , Usher Syndromes/genetics , Vision Disorders/etiology , Zebrafish , Zebrafish Proteins/genetics
3.
Basic Res Cardiol ; 110(2): 3, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25595210

ABSTRACT

Recent reports indicate that elevating DNA glycosylase/AP lyase repair enzyme activity offers marked cytoprotection in cultured cells and a variety of injury models. In this study, we measured the effect of EndoIII, a fusion protein construct that traffics Endonuclease III, a DNA glycosylase/AP lyase, to the mitochondria, on infarct size in a rat model of myocardial ischemia/reperfusion. Open-chest, anesthetized rats were subjected to 30 min of occlusion of a coronary artery followed by 2 h of reperfusion. An intravenous bolus of EndoIII, 8 mg/kg, just prior to reperfusion reduced infarct size from 43.8 Ā± 1.4% of the risk zone in control animals to 24.0 Ā± 1.3% with no detectable hemodynamic effect. Neither EndoIII's vehicle nor an enzymatically inactive EndoIII mutant (K120Q) offered any protection. The magnitude of EndoIII's protection was comparable to that seen with the platelet aggregation inhibitor cangrelor (25.0 Ā± 1.8% infarction of risk zone). Because loading with a P2Y12 receptor blocker to inhibit platelets is currently the standard of care for treatment of acute myocardial infarction, we tested whether EndoIII could further reduce infarct size in rats treated with a maximally protective dose of cangrelor. The combination reduced infarct size to 15.1 Ā± 0.9% which was significantly smaller than that seen with either cangrelor or EndoIII alone. Protection from cangrelor but not EndoIII was abrogated by pharmacologic blockade of phosphatidylinositol-3 kinase or adenosine receptors indicating differing cellular mechanisms. We hypothesized that EndoIII protected the heart from spreading necrosis by preventing the release of proinflammatory fragments of mitochondrial DNA (mtDNA) into the heart tissue. In support of this hypothesis, an intravenous bolus at reperfusion of deoxyribonuclease I (DNase I) which should degrade any DNA fragments escaping into the extracellular space was as protective as EndoIII. Furthermore, the combination of EndoIII and DNase I produced additive protection. While EndoIII would maintain mitochondrial integrity in many of the ischemic cardiomyocytes, DNase I would further prevent mtDNA released from those cells that EndoIII could not save from propagating further necrosis. Thus, our mtDNA hypothesis would predict additive protection. Finally to demonstrate the toxicity of mtDNA, isolated hearts were subjected to 15 min of global ischemia. Infarct size doubled when the coronary vasculature was filled with mtDNA fragments during the period of global ischemia. To our knowledge, EndoIII and DNase are the first agents that can both be given at reperfusion and add to the protection of a P2Y12 blocker, and thus should be effective in today's patient with acute myocardial infarction.


Subject(s)
Endodeoxyribonucleases/pharmacology , Mitochondria/drug effects , Myocardial Infarction/physiopathology , Myocardial Reperfusion Injury/prevention & control , Adenosine Monophosphate/analogs & derivatives , Adenosine Monophosphate/pharmacology , Animals , Deoxyribonuclease I/pharmacology , Disease Models, Animal , Hemodynamics/drug effects , Male , Purinergic P2Y Receptor Antagonists/pharmacology , Rats , Rats, Sprague-Dawley , Recombinant Fusion Proteins/pharmacology
4.
Lasers Surg Med ; 47(4): 361-8, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25740459

ABSTRACT

BACKGROUND AND OBJECTIVE: In regenerative medicine, there are increasing applications of low-level lasers in therapeutic protocols for treatment of diseases in soft and in bone tissues. However, there are doubts about effects on DNA, and an adequate dosimetry could improve the safety of clinical applications of these lasers. This work aimed to evaluate DNA damage in peripheral blood cells of Wistar rats induced by low-level red and infrared lasers at different fluences, powers, and emission modes according to therapeutic protocols. MATERIAL AND METHODS: Peripheral blood samples were exposed to lasers and DNA damage was accessed by comet assay. In other experiments, DNA damage was accessed in blood cells by modified comet assay using formamidopyrimidine DNA glycosylase (Fpg) and endonuclease III enzymes. RESULTS: Data show that exposure to low-level red and infrared lasers induce DNA damage depending on fluence, power and emission mode, which are targeted by Fpg and endonuclease III. CONCLUSION: Oxidative DNA damage should be considered for therapeutic efficacy and patient safety in clinical applications based on low-level red and infrared lasers.


Subject(s)
Blood Cells/radiation effects , DNA Damage/radiation effects , Lasers , Animals , Comet Assay , DNA-Formamidopyrimidine Glycosylase/pharmacology , Endodeoxyribonucleases/pharmacology , Rats, Wistar
5.
Biotechnol Bioeng ; 109(4): 1007-15, 2012 Apr.
Article in English | MEDLINE | ID: mdl-22068567

ABSTRACT

Although Chinese hamster ovary (CHO) cells, with their unique characteristics, have become a major workhorse for the manufacture of therapeutic recombinant proteins, one of the major challenges in CHO cell line generation (CLG) is how to efficiently identify those rare, high-producing clones among a large population of low- and non-productive clones. It is not unusual that several hundred individual clones need to be screened for the identification of a commercial clonal cell line with acceptable productivity and growth profile making the cell line appropriate for commercial application. This inefficiency makes the process of CLG both time consuming and laborious. Currently, there are two main CHO expression systems, dihydrofolate reductase (DHFR)-based methotrexate (MTX) selection and glutamine synthetase (GS)-based methionine sulfoximine (MSX) selection, that have been in wide industrial use. Since selection of recombinant cell lines in the GS-CHO system is based on the balance between the expression of the GS gene introduced by the expression plasmid and the addition of the GS inhibitor, L-MSX, the expression of GS from the endogenous GS gene in parental CHOK1SV cells will likely interfere with the selection process. To study endogenous GS expression's potential impact on selection efficiency, GS-knockout CHOK1SV cell lines were generated using the zinc finger nuclease (ZFN) technology designed to specifically target the endogenous CHO GS gene. The high efficiency (Ć¢ĀˆĀ¼2%) of bi-allelic modification on the CHO GS gene supports the unique advantages of the ZFN technology, especially in CHO cells. GS enzyme function disruption was confirmed by the observation of glutamine-dependent growth of all GS-knockout cell lines. Full evaluation of the GS-knockout cell lines in a standard industrial cell culture process was performed. Bulk culture productivity improved two- to three-fold through the use of GS-knockout cells as parent cells. The selection stringency was significantly increased, as indicated by the large reduction of non-producing and low-producing cells after 25 ĀµM L-MSX selection, and resulted in a six-fold efficiency improvement in identifying similar numbers of high-productive cell lines for a given recombinant monoclonal antibody. The potential impact of GS-knockout cells on recombinant protein quality is also discussed.


Subject(s)
CHO Cells/cytology , Gene Knockout Techniques/methods , Glutamate-Ammonia Ligase/genetics , Animals , Antibodies, Monoclonal/biosynthesis , Batch Cell Culture Techniques , CHO Cells/drug effects , CHO Cells/enzymology , Cell Separation , Cell Survival , Clone Cells/cytology , Clone Cells/drug effects , Clone Cells/enzymology , Cricetinae , Cricetulus , Diploidy , Endodeoxyribonucleases/pharmacology , Exons/drug effects , Flow Cytometry , Glutamine/metabolism , Glutamine/pharmacology , Methionine Sulfoximine/pharmacology , Polyploidy , Recombinant Fusion Proteins/biosynthesis , Selection, Genetic , Transfection , Zinc Fingers
6.
Mutat Res ; 740(1-2): 34-42, 2012 Dec.
Article in English | MEDLINE | ID: mdl-23291497

ABSTRACT

Radiation treatment or chemotherapy has been linked with a higher risk of secondary cancers such as therapy related Acute Myeloid Leukemia (tAML). Several of these cancers have been shown to be correlated to the introduction of double stranded breaks (DSB) and rearrangements within the Mixed Lineage Leukemia (MLL) gene. We used Zinc Finger Nucleases (ZFNs) to introduce precise cuts within MLL to examine how a single DNA DSB might lead to chromosomal rearrangements. A ZFN targeting exon 13 within the Breakpoint Cluster Region of MLL was transiently expressed in a human lymphoblast cell line originating from a CML patient. Although FISH analysis showed ZFN DSB at this region increased the rate of MLL fragmentation, we were unable to detect leukemogenic rearrangements or translocations via inverse PCR. Interestingly, gene fragmentation as well as small interstitial deletions, insertions and base substitutions increased with the inhibition of DNA-PK, suggesting repair of this particular DSB is linked to non-homologous end joining (NHEJ). Although mis-repair of DSBs may be necessary for the initiation of leukemogenic translocations, a MLL targeted DNA break alone is insufficient.


Subject(s)
DNA Breaks, Double-Stranded , Endodeoxyribonucleases/pharmacology , Leukemia, Myeloid, Acute/genetics , Mutagenesis, Insertional/methods , Myeloid-Lymphoid Leukemia Protein/genetics , Cell Line , DNA Fragmentation , DNA Repair , Humans , Mutation , Translocation, Genetic
7.
Int J Immunopathol Pharmacol ; 36: 3946320221130727, 2022.
Article in English | MEDLINE | ID: mdl-36172813

ABSTRACT

BACKGROUND: Lung cancer has the fastest increase in morbidity and mortality, and is one of the most threatening malignant tumors to human health and life. Both radiotherapy and targeted therapy are typical treatments after lung cancer surgery. Radiotherapy is a means of locally killing cancer lesions, and it plays an important role in the entire management of lung cancer. Gefitinib is one of the most commonly used targeted therapy drugs in the treatment of lung cancer. The purpose of this project is to explore the mechanism by which deacetylation of RBBP8 mediated by radiotherapy-promoting protein SIRT6 in lung adenocarcinoma enhances the sensitivity of targeted therapy. METHODS: In both the cell experiments and the animal experiments, the samples were divided into five groups: Model group, RT group, CT group, RT+CT group, and RT+CT+inhibitor group. The CCK8 method was used to detect the viability of each group of cells. The flow cytometry experiment was used to analyze the apoptotic characteristics of each group of cells. The scratch test was used to detect the migration ability of each group of cells. Transwell invasion test was used to determine the invasion ability of each group of cells. The lung tumor tissues of each group of mice were collected to analyze the tumor size, volume, and metastasis characteristics. The TUNEL experiment was used to detect the apoptosis characteristics of the cells in the lung cancer tissues of each group mice. Immunohistochemistry experiments were used to analyze the distribution and relative expression characteristics of protein SIRT6 in mouse lung cancer tissues. The colorimetric experiments were used to detect the activity of Caspase 3 and Caspase 8 in each group. Western blot method was used to detect the expression of SIRT6, RBBP8, and MYC in each group. RESULTS: In each experiment, the results of the experiment have mutually proven consistency, and there is no contradiction. In addition to the Model group, the other 4 groups used different treatment methods. The better the curative effect, the lower the cell viability of cancer cells and the higher the apoptotic ratio. This is reflected in the CCK8 test, flow cytometry analysis, cell scratch test, Transwell cell migration test, and TUNEL detection. At the same time, colorimetric detection and Western blot analysis also analyzed the levels of SIRT6, RBBP8 and other cancer-related proteins in each group at the molecular level, implying the importance of SIRT6 protein in the treatment process. CONCLUSION: Our project has proved that radiotherapy can promote the protein SIRT6 to deacetylate RBBP8 proteins, and ultimately enhance targeted therapy drug sensitivity.


Subject(s)
Adenocarcinoma of Lung , Lung Neoplasms , Sirtuins , Adenocarcinoma of Lung/drug therapy , Adenocarcinoma of Lung/radiotherapy , Animals , Apoptosis , Caspase 3/metabolism , Caspase 8/metabolism , Caspase 8/pharmacology , Cell Line, Tumor , Cell Proliferation , Endodeoxyribonucleases/metabolism , Endodeoxyribonucleases/pharmacology , Gefitinib/pharmacology , Humans , Lung Neoplasms/drug therapy , Lung Neoplasms/pathology , Lung Neoplasms/radiotherapy , Mice , Sirtuins/metabolism
8.
Gene Ther ; 18(2): 135-44, 2011 Feb.
Article in English | MEDLINE | ID: mdl-20668485

ABSTRACT

Encapsidation of cellular- or plasmid-derived DNA sequences during recombinant adeno-associated virus (rAAV) production has been well documented. However, most of the published data were generated from rAAV vectors manufactured by the plasmid transient transfection method. We previously reported a novel, scalable method for rAAV manufacturing based on a recombinant herpes simplex virus (rHSV) complementation system. In this report, we evaluated clearance of DNA impurities during rAAV purification, by determining the quantity of residual herpes simplex virus and cellular DNA at each process step. A single Benzonase treatment during the upstream process effectively reduced unprotected HSV and cellular DNA to <300 bp fragments, and subsequent chromatography steps completely removed these small DNA fragments. Further analysis showed that trace amounts of residual, DNase-resistant HSV and cellular DNA were present at static concentrations during subsequent purification steps, and the residual HSV DNA sequences were single stranded, ranging from 0.8 to 4.2 kb. After transduction of human embryonic kidney 293 cells with purified rAAV, the residual HSV DNA fragments were neither transcribed nor translated into HSV proteins. In summary, this manufacturing process for rAAV production was effective in removing DNA and protein contaminants and achieving a highly purified product, suitable for human clinical application.


Subject(s)
DNA, Viral/analysis , Dependovirus/genetics , Genetic Vectors , Recombination, Genetic , Simplexvirus/genetics , Animals , Cell Line , Cricetinae , Dependovirus/isolation & purification , Endodeoxyribonucleases/pharmacology , Endoribonucleases/pharmacology , Gene Transfer Techniques , HEK293 Cells , Humans , Transduction, Genetic
9.
Am J Physiol Lung Cell Mol Physiol ; 301(6): L892-8, 2011 Dec.
Article in English | MEDLINE | ID: mdl-21890512

ABSTRACT

In cultured pulmonary artery endothelial cells and other cell types, overexpression of mt-targeted DNA repair enzymes protects against oxidant-induced mitochondrial DNA (mtDNA) damage and cell death. Whether mtDNA integrity governs functional properties of the endothelium in the intact pulmonary circulation is unknown. Accordingly, the present study used isolated, buffer-perfused rat lungs to determine whether fusion proteins targeting 8-oxoguanine DNA glycosylase 1 (Ogg1) or endonuclease III (Endo III) to mitochondria attenuated mtDNA damage and vascular barrier dysfunction evoked by glucose oxidase (GOX)-generated hydrogen peroxide. We found that both Endo III and Ogg1 fusion proteins accumulated in lung cell mitochondria within 30 min of addition to the perfusion medium. Both constructs prevented GOX-induced increases in the vascular filtration coefficient. Although GOX-induced nuclear DNA damage could not be detected, quantitative Southern blot analysis revealed substantial GOX-induced oxidative mtDNA damage that was prevented by pretreatment with both fusion proteins. The Ogg1 construct also reversed preexisting GOX-induced vascular barrier dysfunction and oxidative mtDNA damage. Collectively, these findings support the ideas that mtDNA is a sentinel molecule governing lung vascular barrier responses to oxidant stress in the intact lung and that the mtDNA repair pathway could be a target for pharmacological intervention in oxidant lung injury.


Subject(s)
DNA, Mitochondrial/genetics , Endothelial Cells/drug effects , Hydrogen Peroxide/pharmacology , Oxidants/pharmacology , Animals , Cell Fractionation , Cell Nucleus/drug effects , Cell Nucleus/enzymology , DNA Damage , DNA Glycosylases/pharmacology , DNA Glycosylases/physiology , Endodeoxyribonucleases/pharmacology , Endodeoxyribonucleases/physiology , Endothelial Cells/metabolism , Endothelium/metabolism , Glucose Oxidase/chemistry , Glucose Oxidase/pharmacology , Glucose Oxidase/physiology , In Vitro Techniques , Lung/cytology , Lung/drug effects , Male , Mitochondria/drug effects , Mitochondria/enzymology , Permeability , Protein Transport , Rats , Rats, Sprague-Dawley , Recombinant Fusion Proteins/pharmacology , Recombinant Fusion Proteins/physiology
10.
Neoplasma ; 57(4): 339-48, 2010.
Article in English | MEDLINE | ID: mdl-20429625

ABSTRACT

Nuclease from tomato (TBN1) was produced by in planta biotechnology purified and tested for its anticarcinogenic properties. The nuclease was cytostatic after its intratumoral administration to nude mice bearing human melanoma or prostate carcinoma or after tumor targeting by TBN1 administration intravenously as conjugate with polyethylene glycol (PEG). Inhibitory effects of TBN1 on tumor growth were comparable to effects of bovine seminal RNase (BS-RNase), but the inhibition was reached at about ten times lower protein concentration. Simultaneously, TBN1 exhibited a lower degree of embryotoxicity compared to BS-RNAse and other nucleases. TBN1 showed significant stability in vivo, because it was readily detected after its administration intratumorally or intravenously by the fluorescence methods. Intravenous administration of TBN1-PEG caused significant inhibition of tumor proliferation without obvious degenerative changes, while direct administration of TBN1 into melanoma tumors led to rapid tumor tissue degeneration. The fact can be essential for the mode of TBN1 biological action that mature nuclease is a small (36 kDa) thermostable glycoprotein that has ability to destroy human 28S, 18S, 7S and 5.8S RNA, circular RNAs, double-stranded RNA in vitro and shows DNase and 3'nucleotidase activities.


Subject(s)
Antineoplastic Agents/pharmacology , Apoptosis/drug effects , Endodeoxyribonucleases/pharmacology , Melanoma, Experimental/pathology , Prostatic Neoplasms/pathology , Testicular Neoplasms/pathology , Animals , Blotting, Western , Cattle , Embryo, Mammalian/enzymology , Embryo, Mammalian/pathology , Fluorescent Antibody Technique , Glycosylation , Humans , Solanum lycopersicum/enzymology , Male , Mice , Mice, Nude , RNA, Double-Stranded/genetics , RNA, Double-Stranded/metabolism , Recombinant Proteins/therapeutic use , Survival Rate , Tumor Cells, Cultured
11.
J Cell Biol ; 93(3): 670-9, 1982 Jun.
Article in English | MEDLINE | ID: mdl-6214561

ABSTRACT

Spermatocytes of the crane-fly, Nephrotoma suturalis, were attached to electron microscope grids and then sheared by applying centrifugal force. Transmission electron microscopy of exposed regions of the cell cortex revealed networks containing arrays of filamentous structures. Networks were present in sheared spermatocytes at all stages of meiosis. The networks of dividing spermatocytes (meta- through telophase) were denser and appeared to contain more aggregated material then networks of prophase cells. The appearance of networks in spermatocytes resembled actin-containing networks of sheared and detergent-extracted human erythrocytes. Networks treated with myosin subfragment 1 under conditions in which muscle F-actin was clearly decorated were not distinguishable from those of untreated cells. Exposure to deoxyribonuclease-1 caused the disruption of networks in sheared spermatocytes as well as in erythrocytes. The results of deoxyribonuclease experiments are interpreted as an indication that actin is a component of the cell cortex in crane-fly spermatocytes.


Subject(s)
Actins/metabolism , Diptera/metabolism , Spermatocytes/metabolism , Spermatozoa/metabolism , Animals , Cells, Cultured , Centrifugation , Cytoskeleton/drug effects , Cytoskeleton/metabolism , Cytoskeleton/ultrastructure , Deoxyribonuclease I , Endodeoxyribonucleases/pharmacology , Erythrocytes/metabolism , Erythrocytes/ultrastructure , Humans , Male , Spermatocytes/ultrastructure
12.
J Cell Biol ; 93(3): 735-42, 1982 Jun.
Article in English | MEDLINE | ID: mdl-6126482

ABSTRACT

Cytoplasmic streaming in characean algae is thought to be generated by interaction between subcortical actin bundles and endoplasmic myosin. Most of the existing evidence supporting this hypothesis is of a structural rather than functional nature. To obtain evidence bearing on the possible function of actin and myosin in streaming, we used perfusion techniques to introduce a number of contractile and related proteins into the cytoplasm of streaming Chara cells. Exogenous actin added at concentrations as low as 0.1 mg/ml is a potent inhibitor of streaming. Deoxyribonuclease I (DNase I), an inhibitor of amoeboid movement and fast axonal transport, does not inhibit streaming in Chara. Fluorescein-DNase I stains stress cables and microfilaments in mammalian cells but does not bind to Chara actin bundles, thus suggesting that the lack of effect on streaming is due to a surprising lack of DNase I affinity for Chara actin bundles. Heavy meromyosin (HMM) does not inhibit streaming, but fluorescein-HMM (FL-HMM), having a partially disabled EDTA ATPase, does. Quantitative fluorescence micrography provides evidence that inhibition of streaming by FL-HMM may be due to a tendency for FL-HMM to remain bound to Chara actin bundles even in the presence of MgATP. Perfusion with various control proteins, including tubulin, ovalbumin, bovine serum albumin, and irrelevant antibodies, does not inhibit streaming. These results support the hypothesis that actin and myosin function to generate cytoplasmic streaming in Chara.


Subject(s)
Cytoplasmic Streaming/drug effects , Eukaryota/physiology , Proteins/pharmacology , Actins/physiology , Adenosine Triphosphatases/metabolism , Antibodies , Ca(2+) Mg(2+)-ATPase , Cytoskeleton/drug effects , Deoxyribonuclease I , Endodeoxyribonucleases/pharmacology , Myosin Subfragments/pharmacology , Myosins/physiology , Ovalbumin/pharmacology , Serum Albumin/pharmacology , Tubulin/pharmacology
13.
Postepy Biochem ; 55(1): 21-4, 2009.
Article in Polish | MEDLINE | ID: mdl-19514462

ABSTRACT

Benzonase nuclease degrades all forms of DNA and RNA while having no photolytic activity. In this study we check possibility of use this reagent to prepare proteins to microcalorymetric experiments.


Subject(s)
DNA Fragmentation , Endodeoxyribonucleases/pharmacology , Endoribonucleases/pharmacology , RNA Stability , Calorimetry/methods
14.
Article in English | MEDLINE | ID: mdl-29184851

ABSTRACT

Leptospirosis is a global zoonotic infectious disease caused by pathogenic Leptospira species. Leptospire-induced macrophage apoptosis through the Fas/FasL-caspase-8/3 pathway plays an important role in the survival and proliferation of the pathogen in hosts. Although, the release of mitochondrial apoptosis-inducing factor (AIF) and endonuclease G (EndoG) in leptospire-infected macrophages has been described, the mechanisms linking caspase and mitochondrion-related host-cell apoptosis has not been determined. Here, we demonstrated that leptospire-infection induced apoptosis through mitochondrial damages in macrophages. Apoptosis was caused by the mitochondrial release and nuclear translocation of AIF and/or EndoG, leading to nuclear DNA fragmentation. However, the mitochondrion-related CytC-caspase-9/3 pathway was not activated. Next, we found that the release and translocation of AIF and/or EndoG was preceded by the activation of the BH3-interacting domain death agonist (Bid). Furthermore, our data demonstrated that caspase-8 was activated during the infection and caused the activation of Bid. Meanwhile, high reactive oxygen species (ROS) trigged by the infection caused the dephosphorylation of Akt, which also activated Bid. In conclusion, Bid-mediated mitochondrial release of AIF and/or EndoG followed by nuclear translocation is a major mechanism of leptospire- induced apoptosis in macrophages, and this process is modulated by both caspase-8 and ROS-Akt signal pathways.


Subject(s)
Apoptosis Inducing Factor/metabolism , Apoptosis/drug effects , Endodeoxyribonucleases/pharmacology , Leptospira interrogans/pathogenicity , Leptospirosis , Macrophages/drug effects , Mitochondria/metabolism , BH3 Interacting Domain Death Agonist Protein , Caspase 3/metabolism , Caspase 8/metabolism , Caspase 9 , Caspases/metabolism , Cell Nucleus , DNA Fragmentation , Endodeoxyribonucleases/metabolism , Host-Pathogen Interactions/physiology , Humans , Leptospirosis/microbiology , Macrophages/microbiology , Reactive Oxygen Species/metabolism , Signal Transduction , THP-1 Cells
15.
Biochim Biophys Acta ; 1747(1): 121-31, 2005 Feb 14.
Article in English | MEDLINE | ID: mdl-15680246

ABSTRACT

Here we examined the intrinsic nuclease activity of diphtheria toxin (DTx) to determine the mechanism by which it catalyzes DNA degradation. Results show that DTx degrades double-stranded DNA (dsDNA) by non-processive, endonucleolytic attack, without apparent specificity for nucleotide sequence. Moreover, divalent cation composition determines whether supercoiled dsDNA is cleaved by the introduction of single-strand nicks or double-strand breaks. Circular single-stranded DNA (ssDNA) is also a substrate for endonucleolytic attack. Pre-incubation of DTx with a 2000-fold excess of NAD, the natural substrate for the toxin's ADP-ribosyltransferase (ADPrT) activity, inhibited the transfer of radiolabeled ADP-ribose to elongation factor 2 but had no effect on the degradation of radiolabeled DNA. Based on this result and the fact that compounds known to inhibit the ADPrT activity of DTx had no effect on its nuclease activity and pre-incubation of DTx with DNA had no effect on ADPrT activity, we conclude that the ADPrT and nuclease active sites of DTx are functionally and spatially distinct. Moreover, studies with an ADPrT-inactivated form of DTx indicate that nuclease activity alone can lead to target cell lysis.


Subject(s)
Adenosine/analogs & derivatives , DNA/metabolism , Diphtheria Toxin/metabolism , Endodeoxyribonucleases/metabolism , ADP Ribose Transferases/antagonists & inhibitors , ADP Ribose Transferases/pharmacology , ADP Ribose Transferases/physiology , Adenosine/pharmacology , Adenosine Diphosphate Ribose/metabolism , Azides/pharmacology , Binding Sites/physiology , Catalysis , Cations, Divalent/metabolism , Cations, Divalent/pharmacology , Cell Line , Cycloheximide/pharmacology , DNA/drug effects , Diphtheria Toxin/antagonists & inhibitors , Diphtheria Toxin/pharmacology , Endodeoxyribonucleases/antagonists & inhibitors , Endodeoxyribonucleases/pharmacology , Humans , NAD/pharmacology , Niacinamide/pharmacology , Oligoribonucleotides/pharmacology , Peptide Elongation Factor 2/physiology , Protein Biosynthesis/drug effects , Substrate Specificity
16.
Nucleic Acids Res ; 29(11): 2409-17, 2001 Jun 01.
Article in English | MEDLINE | ID: mdl-11376160

ABSTRACT

Extracts of the human glioma cell line A1235 (lacking O(6)-methylguanine-DNA methyltransferase) are known to restore a G:T mismatch to a normal G:C pair in a G:T-containing model (45 bp) DNA substrate. Herein we demonstrate that substitution of G:T with O(6)-methylguanine:T (m6G:T) results in extract-induced intra-strand incision in the DNA at an efficiency comparable to that of complete repair of the G:T-containing substrate, although the m6G:T mispair serves as a poor substrate for later repair steps (e.g. gap filling, as judged by defective DNA repair synthesis). The A1235 extract, when supplemented with ATP and the four normal dNTPs, incises 5' to the mismatched T, as inferred by the generation of a single-stranded 20mer fragment. Unlike its parental (A1235) counterpart, an extract of the alkylation-tolerant derivative cell line A1235-MR4 produces no 20mer fragment, even when thymine-DNA glycosylase (TDG) is added to the reaction mixture. In contrast, the A1235 extract, when augmented with TDG, catalyzes enhanced incision at m6G:T in the 45 bp DNA, yielding 5-10-fold greater 20mer than that of either extract or TDG alone. Interestingly, the absence of m6G:T incision activity in the A1235-MR4 extract is similar to that seen for extracts of several known mismatch repair-deficient cell lines of colon tumor origin. Together these results suggest that derivative A1235-MR4 cells are defective in m6G:T incision activity and that the efficiency of this activity in the parental (A1235) cells may depend on the presence of several ill-defined mismatch repair recognition proteins along with TDG and ATP.


Subject(s)
Base Pair Mismatch/genetics , DNA Repair , DNA/metabolism , Adenosine Triphosphate/pharmacology , Base Sequence , Cell Extracts , Cell-Free System/drug effects , Cell-Free System/metabolism , DNA/chemistry , DNA/genetics , Deoxyribonuclease (Pyrimidine Dimer) , Dose-Response Relationship, Drug , Endodeoxyribonucleases/drug effects , Endodeoxyribonucleases/metabolism , Endodeoxyribonucleases/pharmacology , Guanine/analogs & derivatives , Guanine/chemistry , Guanine/metabolism , HT29 Cells , Humans , Mutation , Nucleotides/pharmacology , Substrate Specificity , Thymine/chemistry , Thymine/metabolism , Tumor Cells, Cultured
17.
Biochim Biophys Acta ; 1049(1): 83-91, 1990 May 24.
Article in English | MEDLINE | ID: mdl-2357468

ABSTRACT

Two kinetically and molecularly distinct forms ('fast' (F) and 'slow' (S] of nuclease BAL 31 from Alteromonas espejiana effect the length reduction of linear duplex DNAs through a 3'----5'-directed exonuclease activity in conjunction with an endonuclease activity against the 5'-terminated single-stranded tails generated by the exonuclease activity. No evidence for a 5'----3' mode of exonuclease action was seen. Single-stranded DNA is degraded predominantly by the 3'----5' exonuclease action. There is a pronounced decrease, to roughly constant values, of the average lengths of the tails in partially digested duplexes at a constant extent of digestion with increasing nuclease concentration. This decrease correlates with an increasing extent of ligatability, in the absence of repair, under conditions favoring the joining of fully base-paired ends. The exonuclease action, at least against duplex substrates, is quasi-processive and removes approx. 18 and 28 nucleotides per productive enzyme-substrate encounter for the S and F species, respectively. The dependence on Ca2+ and Mg2+ concentrations of the activities has been determined.


Subject(s)
DNA, Viral/drug effects , Endodeoxyribonucleases/pharmacology , Bacteriophages/genetics , Calcium/metabolism , Chromatography, High Pressure Liquid , Kinetics , Magnesium/metabolism , Nucleic Acid Denaturation
18.
J Mol Biol ; 176(4): 535-57, 1984 Jul 15.
Article in English | MEDLINE | ID: mdl-6086935

ABSTRACT

Five commonly used nucleases were surveyed for their ability to distinguish among several different DNA backbone configurations. The digestion data suggest that: (1) DNAase I binds across the minor groove; whereas (2) nuclease S1 and (3) micrococcal nuclease bind to an exposed single strand; (4) copper/phenanthroline seeks a base-pair step; and (5) DNAase II requires just a stacked single strand of limited exposure. Only micrococcal nuclease is demonstrably base-specific, with a strong preference for T, A over C, G in any structural context.


Subject(s)
DNA , Deoxyribonucleases/pharmacology , Nucleic Acid Conformation , Autoradiography , Base Composition , Base Sequence , Copper/pharmacology , Copper Sulfate , Deoxyribonuclease I , Endodeoxyribonucleases/pharmacology , Endonucleases/pharmacology , Micrococcal Nuclease/pharmacology , Phenanthrolines/pharmacology , Single-Strand Specific DNA and RNA Endonucleases
19.
J Mol Biol ; 172(4): 417-36, 1984 Feb 05.
Article in English | MEDLINE | ID: mdl-6319718

ABSTRACT

The transcriptional activation and chromatin structure of the alpha 1-globin gene was analyzed during induced erythroid differentiation in murine erythroleukemia cells (MELC). In uninduced MELC, a low level of alpha 1-globin, coding-strand-specific transcription is detectable. Hexamethylene bisacetamide (HMBA)-mediated MELC differentiation is associated with a 10 to 20-fold increase in the rate of alpha 1-globin gene transcription. In induced MELC, alpha 1-globin gene transcription initiated predominantly near the cap site, occurs only off the coding strand, and might terminate, or attenuate, in a region 50 to 250 base-pairs 3' of the polyadenylation site. Before transcriptional activation of the gene, chromatin surrounding the gene displays overlapping DNase I and S1 nuclease sensitive sites, which map to a region 100 to 200 base-pairs 5' of the cap site. After induction, the nuclease sensitivity of these pre-established, overlapping sites increases. In addition, induction generates novel, non-overlapping DNase I and S1 nuclease sensitive sites, which map to regions centered 300 base-pairs 5', and approximately coincident with the cap site, respectively. We compared the time-course of alpha 1-globin transcriptional activation to the chromatin structure changes. A twofold increase in gene transcription is detected within two cell cycles (approximately 24 hours) of exposure of cells synchronized in the G1/early S-phase to inducer. Transcription rates continue to increase for at least 48 hours in MELC cultured with HMBA (the latest time assayed). Chromatin structure changes appear nearly complete after two cell cycles.


Subject(s)
Chromatin/analysis , Gene Expression Regulation , Globins/genetics , Transcription, Genetic , Acetamides/pharmacology , Animals , Cell Line , Chromatin/drug effects , DNA , Deoxyribonuclease I , Endodeoxyribonucleases/pharmacology , Endonucleases/pharmacology , Genes , Leukemia, Erythroblastic, Acute/genetics , Mice , Single-Strand Specific DNA and RNA Endonucleases , Time Factors
20.
J Invest Dermatol ; 101(4): 523-7, 1993 Oct.
Article in English | MEDLINE | ID: mdl-8409517

ABSTRACT

Exposure of skin to ultraviolet (UV) radiation inhibits the induction of delayed-type hypersensitivity (DTH) responses initiated at a distant, unirradiated site. Recent studies attributed this form of immune suppression to DNA damage in the form of cyclobutane pyrimidine dimers (CPD). In the present study, we investigated the protective defects of sunscreens on UV-induced systemic suppression of DTH to Candida albicans, inflammation, and DNA damage. The photoprotective effects of sunscreen preparations containing 8% octyl-N-dimethyl-p-aminobenzoate, 7.5% 2-ethylhexyl-p-methoxycinnamate, or 6% benzophenone-3 were studied in C3H mice exposed to a single dose of 500 mJ/cm2 UVB radiation from FS40 sunlamps. Inflammation was determined by the amount of skin edema at the site of UV irradiation, and DNA damage was assessed by measuring the frequency of endonuclease-sensitive sites in the epidermis. Application of the sunscreens before UV irradiation gave 75-97% protection against UV-induced edema, 67-91% protection against formation of CPD, but only 30-54% protection against suppression of DTH. In contrast, the topical application of liposomes containing a CPD-specific DNA repair enzyme immediately after UV irradiation resulted in 82% protection against suppression of DTH, but at best, 39% protection against skin edema. These findings demonstrate that sunscreens give less protection against UV-induced immune suppression than against skin edema and CPD formation. Furthermore, they suggest that less DNA damage is required to cause UV-induced immune suppression than to cause sunburn.


Subject(s)
DNA Ligases/pharmacology , Dermatitis/etiology , Immunosuppression Therapy , Pyrimidine Dimers/biosynthesis , Sunscreening Agents/pharmacology , Ultraviolet Rays , Animals , Deoxyribonuclease (Pyrimidine Dimer) , Drug Carriers , Endodeoxyribonucleases/administration & dosage , Endodeoxyribonucleases/pharmacology , Female , Hypersensitivity, Delayed/prevention & control , Liposomes , Mice , Mice, Inbred C3H , Radiation Injuries, Experimental , Skin/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL